StreetInsider.com News Articles

Cheelcare Announces First Quarter Fiscal 2027 Financial Results

Fri, 25 Sep 2026 08:00:00 -0400

Markham, Ontario--(Newsfile Corp. - September 25, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced its financial results for the three months ended July 31, 2026. All figures are in CAD unless otherwise noted.

Operational Highlights (Three Months Ended July 31, 2026)

Companion reimbursement and market access: The Company continued to advance Companion's U.S. commercialization following PDAC verification and Medicare and Medicaid reimbursement eligibility received in January 2026, with increased engagement across its dealer, clinician and funding networks.
Canadian patent issued for Companion platform: In May 2026, the Canadian Intellectual Property

Cheelcare Announces First Quarter Fiscal 2027 Financial Results

Fri, 25 Sep 2026 08:00:00 -0400

Operational Highlights (Three Months Ended July 31, 2026)

Companion reimbursement and market access: The Company continued to advance Companion's U.S. commercialization following PDAC verification and Medicare and Medicaid reimbursement eligibility received in January 2026, with increased engagement across its dealer, clinician and funding networks.
Canadian patent issued for Companion platform: In May 2026, the Canadian Intellectual Property

Cheelcare Inc. to Present at the Annual Smallcap Discoveries Conference in Vancouver

Wed, 09 Sep 2026 07:30:00 -0400

Markham, Ontario--(Newsfile Corp. - September 9, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF), (“Cheelcare” or the “Company”), a Canadian innovator in advanced mobility solutions, is pleased to announce that it will be participating in the 2026 Annual Smallcap Discoveries Conference, taking place September 28-29, 2026, at the Parq Hotel & Casino in Vancouver, British Columbia.

Eugene Cherny, CEO & Allan Boyd, VP of Growth, will present an overview of the Company's business, recent operational and financial milestones, growth strategy and outlook. Management will also participate in one-on-one meetings with investors throughout

Cheelcare Inc. to Present at the Annual Smallcap Discoveries Conference in Vancouver

Wed, 09 Sep 2026 07:30:00 -0400

Cheelcare Announces Fourth Quarter and Fiscal 2026 Financial Results and Provides Curio Update

Mon, 31 Aug 2026 07:30:00 -0400

Markham, Ontario--(Newsfile Corp. - August 31, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced its financial results for the fourth quarter and fiscal year ended April 30, 2026. All figures are in CAD unless otherwise noted.

Operational Highlights (Year Ended April 30, 2026)

Continued revenue and Companion sales growth: Fiscal 2026 revenue increased 22% year-over-year to $1.9 million. The Company sold 536 Companion units during the year, compared to 453 in fiscal 2025, representing an 18% increase in annual unit sales.
Companion reimbursement milestone in the United States: On

Cheelcare Announces Fourth Quarter and Fiscal 2026 Financial Results and Provides Curio Update

Mon, 31 Aug 2026 07:30:00 -0400

Operational Highlights (Year Ended April 30, 2026)

Continued revenue and Companion sales growth: Fiscal 2026 revenue increased 22% year-over-year to $1.9 million. The Company sold 536 Companion units during the year, compared to 453 in fiscal 2025, representing an 18% increase in annual unit sales.
Companion reimbursement milestone in the United States: On